Saturday, May 9, 2026
Home Blog Page 436

Biden Could Easily Reschedule Marijuana

The Department of Heath and Human Services and the Justice Department would work together to establish a list of pros and cons for downgrading the Schedule I listing of marijuana to a Schedule II.

While many diehard cannabis advocates are calling for the plant to be legalized in the United States in a manner similar to alcohol and tobacco, President-elect Joe Biden isn’t quite ready to take that leap. Instead, he wants to focus on federally decriminalizing the herb, expanding research opportunities and making it available for medicinal purposes. Interestingly, his pick for health secretary almost solidifies that the nation is indeed headed down such a progressive path. 

Biden announced this week that he wants California Attorney General Xavier Becerra to lead the Department of Health and Human Services. If confirmed, one of his jobs would be to work with a team of health officials to combat the pandemic. The other would be to oversee the orders necessary to reclassify marijuana under the Controlled Substances Act.

Becerra, who was Biden’s second choice after Rhode Island Governor Gina Raimondo turned down the job, is a feather in the cap of cannabis advocates. Not only does he have a solid record on legal cannabis, but he’ll lead the charge of the rescheduling process if Biden makes good on his promise.

Biden’s campaign issued a directive months ago showing exactly what his administration would be willing to do, if elected, to lessen federal cannabis restrictions. “Democrats will decriminalize marijuana use and reschedule it through executive action on the federal level,” the document stated.

Biden wants to put the cannabis plant in a Schedule II listing instead of its current Schedule I. It’s a move that says marijuana “has accepted medical uses,” but a high rate of abuse, so it requires supervision. That process would begin with a health review conducted by Becerra and the HHS.

From there, Becerra and crew would file a petition to reschedule cannabis with the U.S. Attorney General. At the time this article was written, Alabama Senator Doug Jones was said to be the leading contender to oversee the Justice Department. Remember, whoever lands this gig will be selected by Biden because of an alignment of political views and agenda. And Jones is pro-pot. He told reporters in 2019 that the time has come to legalize marijuana. “I think it is about time that we moved it off the controlled states list,” he said. “This is really a states right issue these days.”

Marijuana Could Easily Be Rescheduled With Biden’s Health Secretary
President-elect Joe Biden replaces his face mask after announcing members of his health team, including his pick for secretary of Health and Human Services Xavier Becerraa / Photo by Chip Somodevilla/Getty Images

The HHS and the Justice Department would then work together to establish a list of pros and cons for downgrading the Schedule I listing of marijuana to a Schedule II. If the agencies find the review warrants this action, the attorney general would then initiate the rule-making proceedings to make it happen. Since this request will be made by Biden and not an outside party, we imagine that the rescheduling recommendations will go off without a hitch. After all, the White House would have final say on whether to go full speed ahead with the rescheduling rule.

RELATED: Why A Biden-Appointed, Pro-Cannabis Attorney General Is Important For Weed Reform

Although Biden has made rescheduling marijuana part of his mission, we still don’t have any indication if it will be done in his first 100 days or whether it will be something that takes a backseat until the nation has a grip on COVID. Considering that the House Of Representatives just approved a bill (one that has a companion measure sponsored by Vice President Elect Kamala Harris in the Senate) to legalize marijuana at the federal level, the most likely scenario is that Biden will pick up the issue sooner rather than later.

 RELATED: How Could Joe Biden’s Administration Legalize Marijuana?

One thing is certain, the upcoming administration is set up to make some drastic changes with respect to the cannabis plant. Perhaps then Congress will find the common sense to take larger steps to end prohibition altogether.

Cannabis Holiday Gifts For Every Type Of Friend

Cannabis products make for great gifts. Here are some recommendations for every type of friend, from seasoned stoners to newbies.

Christmas is right around the corner and it’s expected to be a lonelier affair than usual. A simple way to feel closer to your friends this year is to mail them thoughtful gifts. An even better way is to send them thoughtful weed gifts.

Making cannabis gifts is getting easier every year, with new products targeting a wide variety of people, from the canna-curious to seasoned users.

Here are some gift suggestions for this holiday season:

For your friend who needs to relax

CBD Bath Bombs Sound Relaxing, But Do They Work?
Photo by Pharma Hemp Complex via Unsplash

RELATED: Top 10 Benefits Of Vaping Over Smoking

Relaxation is a booming business, especially when paired with CBD. CBD products, no matter how they’re packaged, are devised with relaxation in mind, making them ideal gifts for anyone who’s lived through this crazy year. Brands like Vertly, Rosebud CBD and Prima make great CBD and hemp bath soaks, salts and bombs, leaving people refreshed and smooth-skinned.

For oils and tinctures the market is even larger. Cannabis tinctures and oils tend to promote relaxation and wellness, aptly vague terms that still make for interesting presents. The best reviewed brands include Kanibi, Standard Dose and Pure Kana.

For your friend who’s just learning about weed

 

View this post on Instagram

 

A post shared by @brwnboxkitchen

For friends who want to experiment with cannabis, you can take the CBD route or you can send them some edibles and advise them to take it easy. Brown Box Kitchen provides homemade treats, while popular Kiva Confections offers tailored options.

If your loved one is interested in vaping, you can also send them a disposable THC or CBD pen, which you can find in different styles and prices from G-Pen.

For the seasoned stoner

bong
Photo by secret agent mike/Getty Images

RELATED: 8 Celebrities Cashing In On Cannabis

Seasoned stoners are the toughest ones to please, since they know their way around a joint or a bong and probably already know what they like. If you’ve noticed that your friend has a crappy or musty looking bong, you can splurge and purchase them a nice glass or silicone version. If they’ve never tried a cannabis method like dabbing, you can buy them a dab pen, which is simple, portable and much more accessible than a rig.

For someone who’s hard to shop for

If your friend falls under none of these categories you can always take the cool route. Tokyo Smoke makes some of the coolest looking items out there, from shirts to pens to pipe necklaces, all looking like they were made by a fancy designer, which is actually the case. You don’t always have to use a book cover to roll joints; weed trays are pretty useful and they can actually look great, like this Keith Haring one.

Why Dolly Parton Gets Up At 3 AM

In an interview with RuPaul, Dolly Parton discusses her Christmas movie, cooking in heels, and why she wakes up so darn early every single day.

Dolly Parton is a national treasure, revealed some key insights into her routines. Among them, the fact that she wakes up at 3 a.m. every morning and that she wears high heels when she cooks.

Parton was interviewed by RuPaul for Marie Claire, discussing topics like her daily routines, songwriting process, career, and more. Parton said she’s a very spiritual person, that she prays every morning, usually very early on. “But I’m always, almost always up for good around 3 a.m. So I do some of my best spiritual work, some of my best writing, and some of my business work—call-ins and letters that I’m writing or whatever—between 3 a.m. and 7 a.m,” she said, which is probably a nightmare for her colleagues and is likely the reason why she’s a billionaire who’s written dozens of hit songs.

Does Dolly Parton Smoke Weed?
Photo by Terry Wyatt/Stringer/Getty Images

Aside from waking up at 3 a.m., the 74-year-old said that she only needs between three or five hours of sleep a night, with a little power nap thrown in there when needed.

“I don’t require a lot of sleep. Three to five hours I can work on. Five hours I like to get. But usually I’m between three and five. But usually, if I’m on the job, I’ll take a little power nap.”

RELATED: The Most Popular People And Emojis On Twitter In 2020

Another aspect that might be a key to her success is that she’s always street ready. “I have to keep my makeup on and keep my hair done,” she said. “If we get an earthquake, I’m not running out in the street looking like you look now,” which is a strong dig at Rupaul’s Zoom outfit. When explaining why she wears high heels in the morning she says: “They’re not always as high as the ones I wear for show. But I’m little. I’m short. And I have to wear heels in order to reach my cabinets.”

RELATED: Does Dolly Parton Smoke Weed?

Parton has a Netflix Christmas movie coming up called Christmas On The Square, where she obviously plays an angel. You can read the full interview here if you’re interested in learning more about her wigs, her goddaughter Miley Cyrus and her Christmas album.

The Most Popular People And Emojis On Twitter In 2020

Donald Trump was the most tweeted about person in 2020. Can you guess what the most liked and retweeted tweet of the year was?

By Shivdeep Dhaliwal

Twitter Inc TWTR 0.63% revealed trends that dominated 2020 in its annual review report, released on Monday.

Here are the most tweeted about people and emojis in a year that was dominated by a pandemic that is still ravaging the globe.

2020’s People Of Twitter: This year, the United States saw a presidential election, in which the outgoing President Donald Trump took on the President-Elect Joe Biden, and it comes as no surprise the two candidates took the top spots among the ten most tweeted about people in 2020. Trump topped the charts, followed by Biden. The number three spot was taken by George Floyd, a Black man who died in an encounter with the police in Minnesota in May. Floyd’s death caused widespread protests across the U.S. over racial discrimination.

NBA legend Kobe Bryant, who passed away in a tragic helicopter crash in January, took the number four spot in the list. Other notable people in the list include former President Barack Obama, Tesla Inc CEO 2.78% Elon Musk, Korean band BTS, and India’s Prime Minister Narendra Modi. Vice President-elect Kamala Harris took the number 10 spot on Twitter’s list.

RELATED: 10 Most Tweeted About Celebs Of 2018

The last post from Black Panther actor Chadwick Boseman’s Twitter account, made after his death, was the most liked and retweeted tweet of the year.


Top Emojis This Year: Twitter said that this year people were increasingly grateful or thankful, by up to 20% globally and particularly appreciative of doctors, teachers, and frontline workers. In terms of expressing emotions through Emojis, the most dominant glyph was the tears of joy emoji, followed by sobbing face and pleading face emojis. Notably absent from the top ten list of emojis was the mask face emoji or the fever face emoji.

#Hashtags Of 2020: COVID-19 emerged as the top hashtag of 2020, while #BlackLivesMatter emerged as the second-most trending hashtag as tweets called for equality and social justice following the death of George Floyd.

This article originally appeared on Benzinga and has been reposted with permission.

How The House Approved MORE Act Would Jack Up The Economy

Despite the proven track record of cannabis sales in the U.S., Senate Republicans still refuse to go down the path toward legalization.

For the first time in history, Congress has voted to legalize marijuana in the United States. Well, kind of.

The House of Representatives approved a piece of legislation (MORE Act) last week to eliminate the cannabis plant from the Controlled Substances Act and work to expunge criminal records and dedicate funds to those communities choking on the bones of the drug war. But the bill is not expected to advance with Senate support. More accurately, it’s probably dead in its tracks.

This inaction is mostly because top-ranking Republicans are still morally opposed to legal weed. They argue that the country needs to focus first on fixing the economy crushed by the novel coronavirus and bring jobs back to millions of Americans still waiting on some kind of relief.

But Senate Republicans have forgotten about (or maybe they just don’t want to discuss it) the economic benefits that the U.S. could reap from legal marijuana. Early reports show that nationwide legalization (depending on whether every state jumped on board) would create one million jobs and contribute billions in economic impact. 

The latest predictions from cannabis marketing agency Gram by Gram estimate that job creation could reach closer to 1.63 million by 2025. Considering that millions are still out of work due to the virus, businesses are shutting down by the day, and nobody knows what bogeyman is coming next, legalizing weed could be the most common sense move toward recovery. No, it might not mean salvation for the country in the short term, but it’s hard to argue that House lawmakers aren’t on the right track by proposing legal weed as a long-term solution. 

Marijuana has proven to be a pandemic-proof slice of American commerce. Early on, during the initial wave of shutdowns, many states deemed cannabis dispensaries essential businesses, allowing them to continue servicing customers in uncertain times. And cannabis consumers took full advantage of it, too.

Market data shows that customers weren’t spending any less on weed in states that have legalized it for recreational use, even though they weren’t shopping as frequently to keep from further exposing themselves to the virus. But the cannabis trade was still collecting their cash. In many cases, dispensaries were selling more weed than before the pandemic hit. 

Why Advocates Say MORE Act Falls Short In Restorative Justice
Photo by MmeEmil/Getty Images

Some speculated that thriving weed sales had to do with the extra $600 in unemployment pay from the federal government. That money has since run out, but cannabis sales continue to increase.

RELATED: Why Advocates Say MORE Act Falls Short In Restorative Justice

A new report from global market research provider BDSA (formerly BDS Analytics) shows global cannabis sales for 2020 will hit nearly $20 billion. That is roughly a 40% increase from last year, at a time when populations weren’t being tragically disabled by the economic fallout of the coronavirus. Analysts predict marijuana sales will be closer to $35 billion in the U.S. alone by 2025. 

“While the 2020 forecast is down less than 1% from the forecast released earlier this year, cannabis sales YTD have swung wildly in different states as a result of COVID-19,” Roy Bingham, Co-Founder and Executive Chairman of BDSA said in a statement.

RELATED: The MORE Act Will Not Legalize Cannabis Nationwide — Not Like You’re Thinking

Unfortunately, despite the proven track record of cannabis sales in the U.S., Senate Republicans still refuse to go down the path toward legalization. The only hope the MORE Act has to gain traction is if the Democrats end up flipping the Senate in Georgia’s runoff election in January; a victory would put enough donkey party power behind the bill to get it to the desk of President-elect Joe Biden.

And even though Biden claims not to support full-blown legalization, many believe he might adapt to a more progressive policy if Congress were to find a way to approve it. Again, that’s only possible if the Democrats gain majority control of the Senate. If they don’t, Republicans will surely discount the economic benefits of legal weed for the next few years.

Israel May Soon Legalize Recreational Cannabis

The country is aiming to implement recreational legalization within nine months, and even if there are delays, that means mid-to-late 2021.

A few months ago, I wrote a post entitled, “Israel: Cannabis Powerhouse“. That post noted how Israel has been at the forefront of cannabis for decades. Namely, it was one of the pioneers of cannabis research, an early adopter of medical cannabis, and one of the few countries that has embraced of medical cannabis imports and exports (for example, Israel recently exported medical cannabis to Australia). Nevertheless, Israel still lags behind countries like Canada that have legalized cannabis for recreational purposes. But that’s changing.

RELATED: Israel: Cannabis Powerhouse

As I noted in the above post back in the summer, there had been a preliminary vote in Israel’s Knesset (i.e., its parliament) to push towards a national recreational cannabis market. At the time, this was a huge step toward a legal recreational market. But it ultimately didn’t advance the ball that much until more recently.

In November 2020, Israel announced that it was moving forward with a plan to legalize recreational cannabis nationally. The country is aiming to implement recreational legalization within nine months, and even if there are delays, that means mid-to-late 2021. There’s still a ways to go and more hearings will be held this month.

Ancient Israelites Used Marijuana To Worship God
Photo by Haley Black via Pexels

Israel is reportedly modeling its recreational cannabis law on Canada’s federal laws and will allow sales to persons over 21 years of age, but unlike Canada and many U.S. states, it will not allow home grows (for now, at least). The legislation would also reportedly reform existing medical cannabis laws and decriminalize possession of larger amounts of cannabis.

RELATED: Drone Makes It Rain Marijuana To Protest Cannabis Laws In Israel

A legal recreational market in Israel will be extremely significant. Only a very small handful of other countries have legalized cannabis at the federal level, and other countries are actively resisting recreational legalization, like Germany. Considering the fact that Israel has already embraced imports and exports of medical cannabis, this means it will be lightyears ahead of countries like the United States, which is still struggling to get to federal legalization.

Israel’s recreational cannabis laws have a ways to go, so stay tuned to the Canna Law Blog for more updates.

Griffen Thorne is an attorney at Harris Bricken, a law firm with lawyers in Seattle, Portland, Los Angeles, San Francisco, Barcelona, and Beijing. This story was originally published on the Canna Law Blog and has been reposted with permission.

New Cannabis Company Launches With Sights Set On Awareness For Pet Adoption

“We feel that we can use our unique platform with our cannabis consumers to let them know that there are tons of amazing dogs out there that are ready for a caring home.”

Dogma Cannabis is a cannabis company that has a unique mission to raise awareness about animal shelters and help dogs in California get adopted. Dogma Cannabis was launched by cannabis entrepreneur Geoff Doran in September 2020 and is currently in 3 strategic shops, with plans for a fourth in December. Dogma will be launching its “ready to roll” product in January in addition to the half ounces that they currently have in the California market.

The brand, which is part of the Van Doran portfolio, wants to change the way current cannabis consumers use cannabis by introducing outside of the box products for the consumer that is active, on the move and likes to give back to a cause. The company will be donating a portion of its profits to animal shelters in California.

“Over the last 6 years I have successfully helped launch dozens of brands in the Cannabis industry in California and Colorado. After I acquired two licenses, I finally decided it was time to launch my own brand that had a focus on a cause that I care a lot about. That happens to be animals. It all started after being inspired by a famous individual from my hometown of Springfield, MO,” said Van Doran Brands, CEO & Founder, Geoff Doran.

“That individual was Bob Barker. I met Bob when I first moved to Los Angeles, CA after writing him a letter upon graduation from college. He was actually the first person to give me a shot at an interview right out of college. After that meeting in 2006, I told myself I’d eventually try to give back to animals just like he had done so famously over his career. So with Dogma, I am now able to intertwine two things I care about which is the Cannabis Industry and Animals.”

Doran uses postcards that feature adoptable dogs as a way to promote the brand and also bring attention to the problem facing California dogs. Dr. Kate Hurley, director of the Koret Shelter Medicine Program at UC Davis told KQED in January that an estimated 100,000 animals are euthanized each year in California. Best Friends Animal Society is a nonprofit organization that operates the nation’s largest sanctuary for homeless animals. The organization said California shelters took in 715,000 cats and dogs. Of those, 111,000 were killed. Only Texas (114,000) killed more cats and dogs.

New Cannabis Company Launches With Sights Set On Awareness For Pet Adoption
Photo by Madeline Bowen via Unsplash

Dogma Cannabis officially soft-launched in September with 3 strategic dispensaries in Southern California to test the branding and initial products. “All of our Dogma Cannabis products have been designed to allow our consumers to get a premium flower at a really good price,” said Doran. “In addition to our current products, we will be sticking to the overall cause which is to help animals get adopted.

RELATED: The Relationship Between CBD And Owning Pets Is Deeper Than You Think

“In order to accomplish this, we will be handing out our signature Dogma baseball cards to retailers and consumers to get the word out about adoptable dogs in the Southern California area. We feel that we can use our unique platform with our cannabis consumers to let them know that there are tons of amazing dogs out there that are ready for a caring home.”

If cannabis consumers have a choice between buying plain cannabis versus one that will help these poor animals in shelters, surely they will choose Dogma.

This article originally appeared on Green Market Report and has been reposted with permission. 

Why Advocates Say MORE Act Falls Short In Restorative Justice

Advocacy groups such as Minorities for Medical Marijuana see the MORE Act as continuing to create barriers for those affected by the Drug War. 

A milestone was reached in cannabis reform on December 4 when the U.S. House of Representatives passed the Marijuana Opportunity Reinvestment and Expungement (MORE) Act. But don’t get too excited. 

The bill includes a series of reforms for the industry and those affected by the ongoing drug war. Headlined by the removal of cannabis from the Controlled Substances Act, the MORE Act would also expunge past federal marijuana convictions. Additional parameters would see the creation of an office of cannabis justice to oversee resource allocation to communities most affected by the drug war. 

For businesses, the MORE Act would allow for more access to the Small Business Administration (SBA) while creating grants for equity license opportunities. The bill also aims to expand access to veterans while ensuring that cannabis use is not a factor in a person’s immigration proceedings. 

While 68% of Americans support cannabis reform, the act’s vote saw clear party division, with five Republicans supporting the act and only six Democrats opposing. The vote saw 39 abstentions, resulting in a 228-164 vote. 

The MORE Act is all but assuredly dead on arrival in the Senate, where Majority Leader Mitch McConnell is seen as a deterrent to any further progress during the 116th Congress. 

Largely symbolic, the bill is still being heralded as a milestone win for cannabis reform. 

In a Friday email, the National Organization for the Reform of Marijuana Laws (NORML) said the decision was “huge,” noting it had been decades since Congress had revisited federal legislation.

In a press release, the co-founder and CEO of the National Cannabis Industry Association (NCIA), Aaron Smith, said the win cannot be overstated. “This vote stands as a rebuke of failed and harmful prohibition policies, and represents a growing understanding of their racially and economically disparate impacts,” he said.  

white concrete building under cloudy sky during daytime
Photo by Harold Mendoza via Unsplash

The House passage was not supported by all in the cannabis space. Changes approved the Monday prior to the vote soured support among certain advocates and business leaders. Of the several changes included was an option for federal regulators to prevent the formerly incarcerated from obtaining a business license. 

RELATED: The MORE Act Will Not Legalize Cannabis Nationwide — Not Like You’re Thinking

The parameter lost the support of advocacy groups like Minorities for Medical Marijuana, who see the MORE Act continuing to create barriers for those affected by the Drug War. 

Mary Pryor, an advocate and executive in several cannabis ventures, including Cannaclusive, does not support the bill in its current form. Pryor sees the current bill as a failure to address the disenfranchisement of Black and other minorities because of its exclusion of the formerly incarcerated. 

RELATED: Now That UN Accepts Marijuana, What Excuse Does Congress Have To Uphold Prohibition?

“You’re still singling out and disenfranchising melanated bodies with your policy,” she said. Pryor added that a federal bill failing to include such parameters would negate the efforts made by advocates in specific states where some form of restorative justice has been passed.

Marijuana Prohibition Is The Greatest Scientific Fraud Of The Last Century

Starting with the Indian Hemp Drugs Commission Report in 1893 ending with the US Drug Czar’s own Institute of Medicine report in 1999, no major study has found any basis for the criminalization of cannabis.   

Disclaimer: The views expressed in this article solely belong to the author and do not necessarily represent those of The Fresh Toast. 

Gizmodo.com a website whose motto is “We come from the future” has an article titled, What Is the Biggest Scientific Fraud of the Past 50 Years? It asked some distinguished scientists what they would nominate for that dubious distinction.  So, marijuana prohibition is the greatest scientific fraud of the last century?

Robert N. Proctor, Professor of the History of Science and Professor by courtesy of Pulmonary Medicine at Stanford University, named the “Council for Tobacco Research, the cigarette industry’s chief instrument for denying that cigarettes cause cancer…   

“Twenty-seven Nobel laureates took money from Big Tobacco, and every major university was showered with cash…”  

Considering that tobacco is still killing millions of people around the globe that certainly makes sense. 

RELATED: Remembering Dr. Lester Grinspoon, Intellectual Leader Of The Marijuana Movement

Katherine A. Pandora, Associate Professor, History of Science, The University of Oklahoma, nominated “the opportunistic 1998 and 2002 research articles by Andrew Wakefield and his twelve co-authors that claimed that the MMR (measles, mumps, and rubella) vaccine was linked with the development of autism as the biggest fraud of the last 50 years. The disregard of scientific authorities and the media for strict scrutiny of Wakefield’s claim that was short-handed to ‘vaccines cause autism’ had severe international consequences in terms of vaccine hesitation for childhood illnesses over the last two decades, and still presents ramifications today for the acceptance of COVID-19 vaccine research.” 

However, I think that the fact that no one has nominated marijuana prohibition  is — ironically — proof that it should be the obvious “winner.”  

First, cannabis had been used for millennia without any major health and/or social problems. Starting with the Indian Hemp Drugs Commission Report in 1893 ending with the US Drug Czar’s own Institute of Medicine report in 1999, no major study has found any basis for the criminalization of cannabis.   

SEE: The Institute Of Medicine Report 2.0 

And what have been the consequences? In the United States alone, there have been more than 22 million arrests, continuing even today with over 500,000 arrests in last year. State legislatures are actually passing laws to expunge criminal records. But how do the victims get their lives back?  

It is impossible to measure the harm done by the suppression of medical marijuana. How much suffering, how many deaths were caused by the suppression of medical marijuana just as an antiemetic for cancer chemotherapy? Never mind all the other medical uses that are finally being recognized and researched? 

Of course, marijuana prohibition put cannabis in the same distribution channels as heroin, meth, and cocaine creating the so-called “gateway” to hard drugs.  

How An Endless Drug War Will End Our Freedom
Photo by Spencer Platt/Getty Images

That also led to the extreme violence of the “Drug War” devastating Mexico and other supplier countries. 

And why did it have to include the suppression of hemp as an agricultural staple after millennia? But it did. What has been the impact on the environment? 

There are indeed serious problems with “science.”  

Recently, Vox.com published an excellent article by Kelsey Piper titled: Science has been in a “replication crisis” for a decade. Have we learned anything?: Bad papers are still published. But some other things might be getting better.

It cites John Ioannidis’s 2005 article “Why Most Published Research Findings Are False” 

Of course, when anyone reads the “latest research” it is always good to follow the money. Is the research funded by someone with a financial or political interest in the outcome? If research absolving tobacco as a health problem was funded by the tobacco industry, that does not necessarily mean it is false, but there is a reason that funding and other possible conflicts of interest must be disclosed.  

But what if the government was the funding source. Surely there wouldn’t be a conflict of interest there. Surely. 

Canadian Scientists Researching If Cannabis Can Treat COVID-19 Symptoms
Photo by Wanida Prapan/Getty Images

For example, consider that 85% of all research on “drugs” is funded by NIDA, the National Institute on Drug Abuse. 

And NIDA is not interested in anything that would not support the Drug War in general, but especially marijuana prohibition.  

RELATED: Science Says Medical Marijuana Improves Quality Of Life

A new analysis of cannabis research funding in the United States, Canada, and the United Kingdom has found that $1.56 billion was directed to the topic between 2000 and 2018—with about half of the money spent on understanding the potential harms of the recreational drug. Just over $1 billion came from the biggest funder, the U.S. National Institute on Drug Abuse (NIDA), which doled out far more money to research cannabis misuse and its negative effects than on using cannabis and cannabis-derived chemicals as a therapeutic drug.  

“The government’s budget is a political statement about what we value as a society,” says Daniel Mallinson, a cannabis policy researcher at Pennsylvania State University, Harrisburg, who reviewed the funding analysis provided to Science by the consultant who conducted it. “The fact that most of the cannabis money is going to drug abuse and probably to cannabis use disorder versus medical purposes—that says something.” The data confirm “word on the street” that government grants go to research that focuses on harms, says Daniela Vergara, who researches cannabis genomics at the University of Colorado, Boulder.  

However, overall cannabis research funding in the United States is rising steadily, from less than $30.2 million in 2000 to more than $143 million in 2018, and money to explore cannabis medical treatments is growing—although not as fast as funding for research on harms. 

Meanwhile back in the “real world” the American people, who are the target of the prohibitionist propaganda that they are forced to fund, have been voting overwhelmingly against the government’s policies. The people know that they have been lied to.   

I remember a cartoon from many years ago. A boy is looking skeptically at his breakfast and says to his mother: “You lied to us about marijuana. How do we know you aren’t lying to us about granola?”   

Scientific credibility is a terrible thing to waste.  

Richard Cowan is a former NORML National Director author of the Marijuana, Hemp & CBD Weekly News. Remembering Dr. Lester Grinspoon, Intellectual Leader Of The Marijuana Movement

Most Cannabis Brands Don’t Connect With Customers

The country might be divided, but not on cannabis. Marketers need to recognize that cannabis is no longer on the fringe, but a new opportunity for growth.

Now more than ever before, brands across all industries are attuning to the fact that an in-depth understanding of their audience’s interests and lifestyles is key to robust sales and longevity. The cannabis industry posted that message loud and clear this year, with one online cannabis marketplace, Jane Technologies, Inc. (which partners with over 1,600 dispensaries and brands across 33 states), seeing online Green Wednesday profits for 2020 up 241% over 2019.

Failure to stay relevant to consumers could result in the recent sales boom going bust, yet a recent Forrester Consulting study commissioned by Fyllo, a leading innovator in data, media, and compliance solutions for highly regulated industries, shows many brands lagging behind. According to the study, only 38% of brands understand their customers’ interest in emerging product categories and just 34% can track the current interests and hobbies of their audiences.

The Fyllo-commissioned study was geared towards marketers at top multi-billion dollar consumer brands and how they might leverage cannabis consumer data to improve the ways in which they target audiences with advertisements and media buying. The information was highly sought after. More than three-quarters of brands recognized cannabis and consumer data as not only useful but essential to understanding existing and emerging markets. It’s not just about the ads, but about how and where those advertisements find people— connecting with consumers via their lifestyles and recreational interests.

As Chad Bronstein, CEO and founder of Fyllo observed, “This Forrester data confirms exactly what Election Day represented. The country might be divided, but not on cannabis. Marketers need to recognize that cannabis is no longer on the fringe, but a new opportunity for growth.” A new opportunity indeed.

More Legal Marijuana Equals Less Crime? Not So Fast
Photo by nattrass/Getty Images

Post-November 3rd election results revealed that New Jersey, Arizona, Montana, and South Dakota all voted to legalize adult-use marijuana. Mississippi approved the sale of medical cannabis, bringing the tally of states where cannabis is medically legal to 33. It is now recreationally legal in 12 states and Washington, D.C. Brands would do well to tap into the power of relevant, personalized data to capitalize on the inevitable surge in consumption.

RELATED: Green Wednesday Cannabis Sales Blow Away Black Friday

Almost all brands surveyed in the Forrester study use second-party data for insights into new and existing consumers, and 91% of them agree that staying ahead of not only current but emerging customer interests and lifestyles is a necessity. Yet these brands experience a deficit in their ability to understand their customers at a personal level and to apply this understanding to their media strategies.

RELATED: Global Easing On Cannabis Could Jumpstart Markets

This is where companies like Forrester come in, with the ability to accumulate and activate data effectively and responsibly. With 80% of brands surveyed indicating that they would be interested or very interested in having insights into medical cannabis consumption, while 77% expressed interest in recreational consumption, both the supply of and demand for relevant data are there. Now it’s just a matter of application to create a holistic view of the cannabis customer so that the industry can fully engage its diverse audience and anticipate its evolving needs.

This article originally appeared on Green Market Report and has been reposted with permission.

Don't Miss Your Weekly Dose of The Fresh Toast.

Stay informed with exclusive news briefs delivered directly to your inbox every Friday.

We respect your privacy. Unsubscribe anytime.